DaVita Inc.

194 articles with DaVita Inc.

• DaVita Announces Final Results Of Self-Tender Offer - Sep 17, 2020

  9/17/2020

  DAVITA INC. announced the final results of its modified "Dutch auction" tender offer for up to $1.0 billion of its common stock at a price per share not less than $77.00 and not more than $88.00, which expired at 12:00 midnight, New York City time, at the end of the day on September 14, 2020.

• DaVita Announces Preliminary Results of Self-Tender Offer - Sep 15, 2020

  9/15/2020

  DAVITA INC. announced the preliminary results of its modified "Dutch auction" tender offer for up to $1.0 billion of its common stock at a price per share of not less than $77.00 and not more than $88.00, which expired at 12:00 midnight, New York City time, at the end of the day on September 14, 2020.

• DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock - Aug 17, 2020

  8/17/2020

  DaVita Inc. announced that it has commenced a modified "Dutch auction" tender offer for shares of its common stock for an aggregate purchase price of up to $1.0 billion at a price per share of not less than $77.00 and not more than $88.00.

• DaVita Expands Initiative to Advance Nursing Education

  8/13/2020

  The "Bridge to Your Dreams" program offers DaVita clinical teammates the opportunity to receive financial support to help them earn nursing degrees

• DaVita Announces Paula A. Price to Join its Board of Directors

  8/11/2020

  DaVita Inc. announced that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020.

• DaVita Inc. Announces Offering of $1.5 Billion Senior Notes

  8/6/2020

  DaVita Inc. announced that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031, subject to market and other conditions.

• DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering

  8/6/2020

  DaVita Inc. announced the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031.

• DaVita Inc. Schedules 2nd Quarter 2020 Investor Conference Call

  7/15/2020

  DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time.

• Nephrology Practice Solutions Names New Chief Medical Officer

  5/28/2020

  Dr. Thao Truong Pascual has assumed the clinical leadership role for DaVita's growing nephrology practice management arm

• DaVita Inc. Announces Offering of $1.75 Billion Senior Notes

  5/26/2020

  DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"), subject to market and other conditions. Prior to the closing date of this offering, DaVita will deliver a notice of conditional redemption to holders of its 5.1

• DaVita Inc. Announces Pricing of $1.75 Billion Senior Notes Offering

  5/26/2020

  DaVita Inc. announced the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030.

• DaVita Continues to Support Teammates during COVID-19 Crisis

  5/7/2020

  Kidney care company continues to help teammates by providing relief reimbursement, back-up child care and free counseling

• DaVita Educates Patients to Help Keep Them Safe during COVID-19 Pandemic

  5/4/2020

  Kidney care company supports patients with award-winning education and daily updates

• DaVita Reports on 2019 Corporate Social Responsibility Initiatives

  4/29/2020

  DaVita Inc. released its annual Community Care report, highlighting its commitment to corporate social responsibility and key clinical advancements in 2019..

• DaVita Inc. Schedules 1st Quarter 2020 Investor Conference Call

  4/13/2020

  DaVita Inc., announced that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 5, 2020, at 5:00 p.m. Eastern Time.

• DaVita Inc. Provides Commentary on the COVID-19 Pandemic

  4/13/2020

  DaVita Inc., a leading provider of kidney care services, provided the following commentary regarding the COVID-19 pandemic.

• Focus on Patient Care Brings Industry Together to Fight Crisis

  3/31/2020

  Dialysis Providers Lead the Way to Help Ensure At-risk Patient Population Has Access to Life-sustaining Care

• DaVita Inc. 4th Quarter 2019 Results

  2/10/2020

  DaVita Inc. announced results for the quarter and year ended December 31, 2019..

• DaVita Inc. Schedules 4th Quarter 2019 Investor Conference Call

  1/29/2020

  DaVita Inc., announced that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 10, 2020, at 5:00 p.m. Eastern Time.

• DaVita Inc. 3rd Quarter 2019 Results

  11/5/2019

  DaVita Inc. announced results for the quarter ended September 30, 2019..